FDA Brief

Company record

Roen Health, Inc. dba RoenRx

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Roen Health, Inc. dba RoenRx.

Warning letters

  1. Roen Health, Inc. dba RoenRx

    FDA warned RoenRx that its website misbrands compounded semaglutide with misleading approval claims and a company label implying it makes the drug.

    Medium